Bioventix Statistics
Total Valuation
Bioventix has a market cap or net worth of GBP 206.18 million. The enterprise value is 200.67 million.
Market Cap | 206.18M |
Enterprise Value | 200.67M |
Important Dates
The next estimated earnings date is Thursday, October 24, 2024.
Earnings Date | Oct 24, 2024 |
Ex-Dividend Date | Apr 11, 2024 |
Share Statistics
Bioventix has 5.22 million shares outstanding. The number of shares has increased by 0.90% in one year.
Shares Outstanding | 5.22M |
Shares Change (YoY) | +0.90% |
Shares Change (QoQ) | -0.39% |
Owned by Insiders (%) | 6.00% |
Owned by Institutions (%) | 62.46% |
Float | 4.23M |
Valuation Ratios
The trailing PE ratio is 24.19 and the forward PE ratio is 22.87.
PE Ratio | 24.19 |
Forward PE | 22.87 |
PS Ratio | 15.16 |
PB Ratio | 18.03 |
P/FCF Ratio | 25.80 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.45, with an EV/FCF ratio of 25.11.
EV / Earnings | 23.16 |
EV / Sales | 14.76 |
EV / EBITDA | 18.45 |
EV / EBIT | 18.66 |
EV / FCF | 25.11 |
Financial Position
The company has a current ratio of 7.04
Current Ratio | 7.04 |
Quick Ratio | 6.69 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 79.14% and return on invested capital (ROIC) is 61.38%.
Return on Equity (ROE) | 79.14% |
Return on Assets (ROA) | 54.07% |
Return on Capital (ROIC) | 61.38% |
Revenue Per Employee | 1.13M |
Profits Per Employee | 722,123 |
Employee Count | 12 |
Asset Turnover | 1.09 |
Inventory Turnover | 1.53 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.61% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +4.61% |
50-Day Moving Average | 4,296.20 |
200-Day Moving Average | 4,391.60 |
Relative Strength Index (RSI) | 27.08 |
Average Volume (20 Days) | 3,362 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioventix had revenue of GBP 13.60 million and earned 8.67 million in profits. Earnings per share was 1.63.
Revenue | 13.60M |
Gross Profit | 12.75M |
Operating Income | 10.75M |
Pretax Income | 10.86M |
Net Income | 8.67M |
EBITDA | 10.88M |
EBIT | 10.75M |
Earnings Per Share (EPS) | 1.63 |
Balance Sheet
Cash & Cash Equivalents | 5.51M |
Total Debt | n/a |
Net Cash | 5.51M |
Net Cash Per Share | 1.05 |
Equity (Book Value) | 11.43M |
Book Value Per Share | 2.19 |
Working Capital | 10.31M |
Cash Flow
In the last 12 months, operating cash flow was 8.00 million and capital expenditures -5,321, giving a free cash flow of 7.99 million.
Operating Cash Flow | 8.00M |
Capital Expenditures | -5,321 |
Free Cash Flow | 7.99M |
FCF Per Share | 1.53 |
Margins
Gross margin is 93.75%, with operating and profit margins of 79.09% and 63.73%.
Gross Margin | 93.75% |
Operating Margin | 79.09% |
Pretax Margin | 79.85% |
Profit Margin | 63.73% |
EBITDA Margin | 79.99% |
EBIT Margin | 79.09% |
FCF Margin | 58.77% |
Dividends & Yields
This stock pays an annual dividend of 1.52, which amounts to a dividend yield of 3.82%.
Dividend Per Share | 1.52 |
Dividend Yield | 3.82% |
Dividend Growth (YoY) | -2.47% |
Years of Dividend Growth | n/a |
Payout Ratio | 91.53% |
Buyback Yield | -0.90% |
Shareholder Yield | 2.92% |
Earnings Yield | 4.13% |
FCF Yield | 3.88% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |